Regeneron
Venture capital · Tarrytown, New York, United States
Portfolio collected from the firm’s website, last checked Jun 28, 2026.Raises and exits come from each company’s own SEC and company records.
5Deep-tech portfolio2 active
3Portfolio exitsAcquired or listed
0Raises, 12 monthsLatest: Decibel Therapeutics
23Co-investorsShare a portfolio company
Portfolio · 5 companies
| Company | Sector | Status | Latest raise | Raised |
|---|---|---|---|---|
| Lyell Immunopharma | Biotech | Active | Mar 20, 2020 | $493.0M |
| AP Neomorph | Biotech | Active | — | — |
| Decibel Therapeutics | Biotech | Acquired | Nov 12, 2020 | $62.8M |
| Prevail Therapeutics | Biotech | Acquired | Mar 14, 2018 | $57.0M |
| Intellia Therapeutics | Biotech | Public | Sep 3, 2015 | $70.0M |
Peer ranks
Portfolio size#81
Portfolio exits#69
Raises, 12 months#88
Co-investors#90
Co-investors
- Atlas VentureVenture capital2 shared
- Deerfield Capital ManagementVenture capital2 shared
- RA CapitalVenture capital2 shared
- Third Rock VenturesVenture capital2 shared
- Amgen VenturesVenture capital1 shared
- ARCH VentureVenture capital1 shared
- Bessemer Venture PartnersVenture capital1 shared
- Biotechnology Value FundVenture capital1 shared
- Cormorant Asset ManagementVenture capital1 shared
- Foresite CapitalVenture capital1 shared
Sectors
- Biotech5
Portfolios are collected from investors’ own websites and matched to tracked deep-tech companies by name; duplicate listings of the same firm are merged. Exits and raises come from each company’s own record: Form D through the latest filing.